Intelligence · Clinical Development
Pipeline search results
Programs matching “air” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 160 pipeline programs matching "air" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
TD-4208
Theravance Biopharma Ireland Umited
Renal Impairment
1 trial -
Tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Renal Impairment
1 trial -
Tebipenem pivoxil hydrobromide (TBPM-PI-HBr)
Spero Therapeutics
Renal Impairment
1 trial -
Teduglutide
Takeda
Hepatic Impairment
1 trial -
Telotristat Ethyl
LEXICON PHARMACEUTICALS, INC.
Hepatic Impairment
1 trial -
VIR-2218
Vir Biotechnology
Hepatic Impairment
1 trial -
VIR-2218
Vir Biotechnology
Renal Impairment
1 trial -
Vadadustat
Akebia Europe Limited
Hepatic Impairment
1 trial -
Visual Sputum Suctioning System
The First People's Hospital of Lianyungang
Ineffective Airway Clearance
1 trial -
Vortioxetine
Takeda
Severe Hepatic Impairment
1 trial -
WA45032
Hoffmann-La Roche
Hepatic Impairment
1 trial -
Yimitasvir Phosphate
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Hepatic Impairment
1 trial -
Yimitasvir Phosphate Capsule
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Renal Impairment
1 trial -
ZP8396-25077
Zealand Pharma A/S
Healthy / hepatic impaired volunteers only study to assess PK parameters
1 trial -
belapectin
GALECTIN THERAPEUTICS INC
Hepatic Impairment
1 trial -
lofexidine HCl
BRIGHT MINDS BIOSCIENCES INC.
Renally Impaired Subjects
1 trial -
lumacaftor 200 mg q12h + ivacaftor 250 mg q12h
Vertex Pharmaceuticals (Australia) Pty.
Hepatic Impairment
1 trial -
questionnaires
Cardiff Oncology
Anxiety
1 trial -
sotagliflozin
LEXICON PHARMACEUTICALS, INC.
Hepatic Impairment
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Hepatic Impairment
1 trial -
AO-128
Takeda
Impaired Glucose Tolerance (IGT)
1 trial -
Advair Diskus100/50 µg
Teva Pharma GmbH
Asthma
1 trial -
AirDuo Digihaler
Teva Pharma GmbH
Asthma
1 trial -
D8223C00016
AstraZeneca AB
Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.